358 related articles for article (PubMed ID: 22399212)
1. Hemolytic disease of the newborn caused by irregular blood subgroup (Kell, C, c, E, and e) incompatibilities: report of 106 cases at a tertiary-care centre.
Karagol BS; Zenciroglu A; Okumus N; Karadag N; Dursun A; Hakan N
Am J Perinatol; 2012 Jun; 29(6):449-54. PubMed ID: 22399212
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
[TBL] [Abstract][Full Text] [Related]
3. Hemolytic disease of the newborn due to isoimmunization with anti-E antibodies: a case report.
Sarici SU; Alpay F; Yeşilkaya E; Ozcan O; Gökçay E
Turk J Pediatr; 2002; 44(3):248-50. PubMed ID: 12405439
[TBL] [Abstract][Full Text] [Related]
4. Hemolytic Anemia and Heart Failure Caused by Anti-C and Anti-E Immunization.
Bilgin H; Eren A; Kara S
J Coll Physicians Surg Pak; 2016 Jun; 26(6):539-40. PubMed ID: 27353998
[TBL] [Abstract][Full Text] [Related]
5. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
Wenk RE; Goldstein P; Felix JK
Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
[TBL] [Abstract][Full Text] [Related]
6. [Irregular blood group antibodies during pregnancy: screening is mandatory].
Semmekrot BA; de Man AJ; Boekkooi PF; van Dijk BA
Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1449-52. PubMed ID: 10443258
[TBL] [Abstract][Full Text] [Related]
7. Severe hemolytic disease of the newborn caused by anti-Gonzales antibody.
Leschek E; Pearlman SA; Boudreaux I; Meek R
Am J Perinatol; 1993 Sep; 10(5):362-4. PubMed ID: 8240594
[TBL] [Abstract][Full Text] [Related]
8. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
[TBL] [Abstract][Full Text] [Related]
9. [Icterus gravis and exchange transfusion].
Tulzer W; Griebler T
Wien Med Wochenschr; 1967 Apr; 117(13):334-7. PubMed ID: 4968441
[No Abstract] [Full Text] [Related]
10. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
11. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of single versus double volume exchange transfusion in newborn infants with AB0 hemolytic disease.
Amato M; Blumberg A; Hermann U; Zurbrügg R
Helv Paediatr Acta; 1988 Nov; 43(3):177-86. PubMed ID: 3220789
[TBL] [Abstract][Full Text] [Related]
13. [Hemolytic disease of the newborn and irregular blood group antibodies in the Netherlands: prevalence and morbidity].
van Dijk BA; Hirasing RA; Overbeeke MA
Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1465-9. PubMed ID: 10443262
[TBL] [Abstract][Full Text] [Related]
14. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.
Chen JY; Ling UP
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jan; 53(1):13-8. PubMed ID: 8173995
[TBL] [Abstract][Full Text] [Related]
16. Exchange transfusions and top-up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease.
Rath ME; Smits-Wintjens VE; Lindenburg IT; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
Vox Sang; 2011 Apr; 100(3):312-6. PubMed ID: 20849463
[TBL] [Abstract][Full Text] [Related]
17. Recurrence rate of ABO hemolytic disease of the newborn.
Katz MA; Kanto WP; Korotkin JH
Obstet Gynecol; 1982 May; 59(5):611-4. PubMed ID: 7070734
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of hemolysis.
Zipursky A
Mead Johnson Symp Perinat Dev Med; 1982; (19):17-24. PubMed ID: 6821465
[TBL] [Abstract][Full Text] [Related]
19. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
[TBL] [Abstract][Full Text] [Related]
20. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
